COVID-19 vaccine (BNT162b2, with Pfizer)

URI: https://gptkb.org/entity/COVID-19_vaccine_(BNT162b2,_with_Pfizer)

GPTKB entity

Statements (63)

Predicate	Object
gptkbp:instanceOf	vaccine
gptkbp:administeredBy	over 100 countries
gptkbp:age	12 years and older
gptkbp:alsoKnownAs	gptkb:Comirnaty gptkb:Pfizer-BioNTech_COVID-19_vaccine
gptkbp:approvedBy	gptkb:World_Health_Organization gptkb:European_Medicines_Agency gptkb:U.S._Food_and_Drug_Administration
gptkbp:boosterFormulation	bivalent (Omicron-adapted)
gptkbp:boosterRecommended	yes
gptkbp:clinicalTrialPhase	July 2020 - November 2020
gptkbp:contains	gptkb:ALC-0159 gptkb:ALC-0315 gptkb:DSPC gptkb:PEG2000 sodium chloride potassium chloride saline sucrose cholesterol lipid nanoparticles dibasic sodium phosphate dihydrate monobasic potassium phosphate nucleoside-modified mRNA
gptkbp:countryOfOperation	gptkb:Australia gptkb:Brazil gptkb:Canada gptkb:European_Union gptkb:India gptkb:Israel gptkb:Japan gptkb:South_Africa gptkb:United_Kingdom gptkb:United_States
gptkbp:developedBy	gptkb:Pfizer gptkb:BioNTech
gptkbp:efficacyAgainstOriginalStrain	~95%
gptkbp:emergencyServices	December 2020
gptkbp:firstAdministered	gptkb:Margaret_Keenan
gptkbp:firstAdministeredCountry	gptkb:United_Kingdom
gptkbp:firstAdministeredDate	8 December 2020
gptkbp:form	2 doses, 3 weeks apart
gptkbp:fullApprovalDate	August 2021
https://www.w3.org/2000/01/rdf-schema#label	COVID-19 vaccine (BNT162b2, with Pfizer)
gptkbp:manufacturer	gptkb:Belgium gptkb:Germany gptkb:United_States
gptkbp:patent	gptkb:Pfizer gptkb:BioNTech
gptkbp:pregnancyCategory	consult healthcare provider
gptkbp:routeOfAdministration	intramuscular injection
gptkbp:sideEffect	fever fatigue headache muscle pain chills injection site pain
gptkbp:storage	-70°C
gptkbp:target	gptkb:COVID-19
gptkbp:type	vaccine
gptkbp:WHOEmergencyUseListing	December 2020
gptkbp:bfsParent	gptkb:BioNTech_US_Inc.
gptkbp:bfsLayer	6